← Back to Search

Resiliency & Burnout Interventions for Behavioral Health Staff

N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare two interventions to reduce burnout, improve resiliency, and reduce turnover in group homes for adults with serious mental illness and/or developmental/intellectual disabilities. Researchers will measure the effectiveness of each intervention.

Who is the study for?
This trial is for permanent-salary staff at certain group homes for adults with serious mental illness or intellectual and developmental disabilities. It's not open to temporary or per diem workers, nor staff at non-participating group homes.
What is being tested?
The study compares two programs: Integrated Resiliency Training and Task Sharing (IRTTS) versus Workplace Improvement Learning Collaborative (WILC). It looks at which is better for improving staff resiliency, stress management, health behaviors, job retention, safety in the home, and reducing burnout.
What are the potential side effects?
Since this trial involves training sessions and collaborative work rather than medical treatments, traditional side effects are not expected. However, participants may experience changes in stress levels or emotional states due to the nature of the interventions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Resilience (12-month follow-up)
Resilience (3-month follow-up)
Resilience (baseline)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Workplace Improvement Learning CollaborativeExperimental Treatment1 Intervention
A workplace improvement learning collaborative implemented at the organization level (mesosystem).
Group II: Integrated Resiliency Training and Task SharingExperimental Treatment2 Interventions
A multi-component intervention combining resiliency training and task sharing implemented at the site-level (microsystem).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resiliency Training
2014
N/A
~5520

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
3,006 Previous Clinical Trials
13,306,382 Total Patients Enrolled
Patient-Centered Outcomes Research InstituteOTHER
573 Previous Clinical Trials
27,077,402 Total Patients Enrolled
VinfenUNKNOWN
2 Previous Clinical Trials
1,205 Total Patients Enrolled

Media Library

Resiliency Training Clinical Trial Eligibility Overview. Trial Name: NCT05806112 — N/A
Burnout Research Study Groups: Integrated Resiliency Training and Task Sharing, Workplace Improvement Learning Collaborative
Burnout Clinical Trial 2023: Resiliency Training Highlights & Side Effects. Trial Name: NCT05806112 — N/A
Resiliency Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05806112 — N/A
~595 spots leftby Feb 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top